Lumertam20mg+120mg

• Acute, uncomplicated malaria caused by Plasmodium falciparum
• Mixed malaria infections including P. falciparum
• Effective against chloroquine-resistant malaria parasites
• Active against blood stages of P. vivax

Weight-based Dosing:

• ≥35 kg: 6-dose course (total 24 tablets) - 4 tablets initially, 4 after 8 hours, then 4 tablets twice daily for 2 days
• 25-35 kg: 3 tablets per dose (total 18 tablets)
• 15-25 kg: 2 tablets per dose (total 12 tablets)
• 5-15 kg: 1 tablet per dose (total 6 tablets)

Each tablet contains 20 mg artemether and 120 mg lumefantrine. Take with food (especially fatty food or milk) to enhance absorption.

• Headache
• Dizziness
• Loss of appetite
• Weakness
• Muscle and joint pain
• Nausea and vomiting
• Abdominal pain
• Diarrhea
• Rash
• Cough
• Abnormal gait

Serious Precautions:

• Not indicated for malaria prophylaxis.
• Not evaluated for cerebral malaria or severe malaria complications.
• Contraindicated in the first trimester of pregnancy.
• Avoid use during breastfeeding - discontinue breastfeeding for 28 days after last dose.
• Use with caution in patients at risk of QT prolongation.
• May cause dizziness - use caution while driving or operating machinery.
• If vomiting occurs within 1 hour, take another dose.
• Inform your doctor if you have kidney, liver, or heart disease.